Feng-chun Cai Selected Research

Hyperamylasemia

7/2013

Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feng-chun Cai Research Topics

Disease

2	Hemorrhage 04/2014 - 12/2007
1	Infections 04/2014
1	Hyperamylasemia 07/2013
1	Pancreatitis 07/2013
1	Varicose Veins (Varicose Vein) 12/2007
1	Embolism (Embolus) 12/2007
1	Esophageal and Gastric Varices (Esophageal Varices) 12/2007

Drug/Important Bio-Agent (IBA)

1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2013
1	CyanoacrylatesIBA 12/2007
1	Iodized OilIBA 12/2007

Therapy/Procedure

1	Stents 04/2014
1	Sclerotherapy 12/2007
1	Therapeutics 12/2007